Genocea Biosciences reported $24.41M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US $ 290.48M 41.49M
Baxter International BAX:US $ 8173M 699M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Cytokinetics CYTK:US $ 623.53M 87.85M
Cytori Therapeutics CYTX:US $ 22.1M 2.38M
Genocea Biosciences GNCA:US $ 24.41M 17.41M
Glaxosmithkline GSK:US $ 28988M 10314M
Infinity Pharmaceuticals INFI:US $ 70.1M 12.17M
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Moderna Inc MRNA:US 16.35B 279M
Novavax NVAX:US $ 2347.41M 192.29M
Pfizer PFE:US $ 54420M 5273M
Prothena PRTA:US 555.62M 29.19M